NetworkNewsBreaks – Pivot Pharmaceuticals Inc. (
Post# of 52
(Total Views: 239)
Posted On: 06/15/2018 4:33:47 PM
NetworkNewsBreaks – Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) Leveraging Proprietary Technology in Innovative Cannabinoid Product Pipeline
Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) is leveraging innovative technology to target pain and a number of chronic conditions. A recent article discussing this reads, “These proprietary technologies are deployed in the development of cannabidiol (CBD) and tetrahydrocannabinol (THC) based products. Pivot’s cannabinoid pipeline of pharmaceutical products includes two that use the Solmic drug delivery technology for cancer supportive care, targeting the relief of mucositis and chemotherapy-induced nausea and vomiting. The company has also deployed its Bi-Phasix™ delivery platform for the development of four products that target women’s sexual desire disorder, glaucoma, dysmenorrhea and dermatological conditions. Pivot’s development pipeline also contains products for the relief of restless leg syndrome, opioid withdrawal and the treatment of pain and inflammation.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) is leveraging innovative technology to target pain and a number of chronic conditions. A recent article discussing this reads, “These proprietary technologies are deployed in the development of cannabidiol (CBD) and tetrahydrocannabinol (THC) based products. Pivot’s cannabinoid pipeline of pharmaceutical products includes two that use the Solmic drug delivery technology for cancer supportive care, targeting the relief of mucositis and chemotherapy-induced nausea and vomiting. The company has also deployed its Bi-Phasix™ delivery platform for the development of four products that target women’s sexual desire disorder, glaucoma, dysmenorrhea and dermatological conditions. Pivot’s development pipeline also contains products for the relief of restless leg syndrome, opioid withdrawal and the treatment of pain and inflammation.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)